Rapport Therapeutics: BTIG raises target price to $89 from $75
RAPP•BTIG raised its target price for Rapport Therapeutics to $89 from $75.
Related News
Aging populations strain global pension systems, Marsh report finds
MRSH•
Xwell receives Nasdaq notice for failure to meet minimum bid price requirement
XWEL•
Singapore's Genius Group Q3 revenue surges, swings to profit
GNS•
Skyworks publishes update to financial calendar
SWKS•
Boeing introduces new aircraft data intelligence platform
BA•